Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
53,599,048
-
Total 13F shares
-
31,409,972
-
Share change
-
+9,791,190
-
Total reported value
-
$1,264,282,974
-
Put/Call ratio
-
160%
-
Price per share
-
$40.25
-
Number of holders
-
76
-
Value change
-
+$428,153,179
-
Number of buys
-
54
-
Number of sells
-
22
Institutional Holders of SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO) as of Q4 2023
As of 31 Dec 2023 SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO) had 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 31,409,972 shares of stock of the company.
Largest 10 holders included Vivo Capital, LLC, PERCEPTIVE ADVISORS LLC, Carlyle Group Inc., Nantahala Capital Management, LLC, JANUS HENDERSON GROUP PLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Vestal Point Capital, LP, VANGUARD GROUP INC, BALYASNY ASSET MANAGEMENT L.P., and Avoro Capital Advisors LLC.
This table shows 76 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.